We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles
PeriodicalsMedical Sciences

Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles

Checking your access to this record.

Abstract & Overview

Mendelian randomisation is an accessible and valuable epidemiological approach to provide insight into the causal nature of relationships between risk factor exposures and disease outcomes. However, if performed without critical thought, we may simply have replaced one set of implausible assumptions (no unmeasured confounding or reverse causation) with another set of implausible assumptions (no pleiotropy or other instrument invalidity). The most critical decision to avoid pleiotropy is which genetic variants to use as instrumental variables. Two broad strategies for instrument selection are a biologically motivated strategy and a genome-wide strategy; in general, a biologically motivated strategy is preferred. In this review, we discuss various ways of implementing a biologically motivated selection strategy: using variants in a coding gene region for the exposure or a gene region that encodes a regulator of exposure levels, using a positive control variable and using a biomarker as the exposure rather than its behavioural proxy. In some cases, a genome-wide analysis can provide important complementary evidence, even when its reliability is questionable. In other cases, a biologically-motivated analysis may not be possible. The choice of genetic variants must be informed by biological and functional considerations where possible, requiring collaboration to combine biological and clinical insights with appropriate statistical methodology.

Cite this record

Stephen Burgess, Héléne T. Cronjé (2024). Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles. eGastroenterology, 2(1), e100042–e100042. https://doi.org/10.1136/egastro-2023-100042

Copy in another style

Burgess, S., & Cronjé, H. T. (2024). Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles. eGastroenterology, 2(1), e100042–e100042. https://doi.org/10.1136/egastro-2023-100042
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.